Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
Top Cited Papers
- 1 August 2011
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 10 (8) , 745-758
- https://doi.org/10.1016/s1474-4422(11)70149-1
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Association of melanoma and natalizumab therapy in the Italian MS population: a second case reportNeurological Sciences, 2010
- Swedish natalizumab (Tysabri) multiple sclerosis surveillance studyNeurological Sciences, 2010
- Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational studyNeurological Sciences, 2010
- Natalizumab treatment in multiple sclerosis: the experience of S. Andrea MS Centre in RomeNeurological Sciences, 2010
- Asymptomatic Reactivation of JC Virus in Patients Treated with NatalizumabNew England Journal of Medicine, 2009
- Natalizumab and central nervous system lymphoma: No clear associationAnnals of Neurology, 2009
- Identification and Characterization of Mefloquine Efficacy against JC Virus In VitroAntimicrobial Agents and Chemotherapy, 2009
- PML-IRIS in patients with HIV infectionNeurology, 2009
- GLANCENeurology, 2009
- Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte functionNeurology, 2009